Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
|
Value Stock, Under Radar
1142.4000
-5.40
(
-0.47
%)
NSE
Jun 02, 2025
12:45 PM
28.24% Fall from 52W High
Volume:
725.8K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
10 Feb 2025
1142.40
-0.47%
Result Update:Aurobindo Pharma
Buy:
Aurobindo Pharma Ltd.
by
Axis Direct
Target: 1500 | Upside : 31.3%
Target
Axis Direct
We maintain our BUY recommendation on Aurobindo Pharma with a target price of Rs 1,500/share
Number of FII/FPI investors decreased from 730 to 724 in Mar 2025 qtr
More from Aurobindo Pharma Ltd.
Recommended
Market trades lower, Nykaa's Q4 revenue misses Forecaster estimates by 0.8%
Trendlyne Marketwatch |
02 Jun 2025, 12:30PM
Five Interesting Stocks Today - May 30, 2025
The Baseline |
30 May 2025
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020